Molecular Quality Controls Market size will gain noticeable traction between 2023 and 2032, driven by the increase in cases of HIV, cancers, and other diseases. Molecular quality control is the testing and reporting done of any irregularity in diagnostic products. Early detection of possible anomalies is crucial for labs, as it helps them execute a timely response and avert negative impacts on patient data. Molecular labs use thorough quality control procedures to supervise the testing for systematic as well as random errors. It also helps to detect immediate shifts in data & abnormalities in long-term trends.
The persistent rise in the number of clinical laboratories will favor market outlook. Moreover, the setting up of new clinical facilities will create a prompt progress for monitoring and testing services for potential irregularities in diagnostic products. This could augment the progression for molecular quality control solutions over the forthcoming years.
Based on application, the molecular quality controls market from the oncology segment is expected to record extensive gains by 2032. New research efforts on cancer and associated biomarkers are a major driver behind this development. According to the European Society of Medical Oncology, cancer incidence will increase by almost 21% by 2040. New efforts related to biomarker discovery will supplement market expansion in the oncology segment.
Geographically, the Asia Pacific molecular quality control industry size is poised to expand by 2032, due to the increased demand for accurate and high-quality diagnostic tests. With cancer becoming a key health concern in the Asia-Pacific countries, the requirement for precision oncology has been a major area of ??focus for various authorities in the region. The presence of an aging population and changing lifestyles have led to the establishment of various initiatives. Some of these initiatives include the introduction of platforms such as Japan’s LC-SCRUM lung cancer genomic screening project and the Korean Cancer Precision Medicine Diagnosis & Treatment Enterprise (K-MASTER) in South Korea.
Some of the major players in the molecular quality controls market include Abbott Laboratories, Bio-Rad Laboratories Inc, Quidel Corporation, Microbiologics Inc, Molecular Quality Controls Inc. Thermo Fisher Scientific, SeraCare Life Sciences Inc, Roche Diagnostics, and ZeptoMetrix Corporation (Antylia Scientific).
The ongoing conflict between Russia and Ukraine can have several implications for various industries, including the molecular quality control market. The sanctions imposed by the international community on Russia due to its actions in Ukraine can lead to a decrease in the import and export of goods and services, which can cause disruptions in the supply chain of molecular quality controls. The instability in the region can also affect investment and business confidence, which can impact the growth of the market.